Class action lawsuits
Purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024, and June 30, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has already been filed, and investors have until September 8, 2025, to
Class action lawsuits
Class action lawsuit against KinderCare Learning Companies, Inc. highlights alleged violations of federal securities laws, including failure to comply with laws and regulations related to child care. The company's initial public offering in October 2024 is at the center of the lawsuit, with shareholders encouraged to contact the
Class action lawsuits
A class action lawsuit has been filed in the United States District Court for the Northern District of California against Alto Neuroscience, Inc. and certain officers on behalf of investors who purchased or acquired the company's common stock during an initial public offering (IPO) in February 2024 and
Class action lawsuits
A shareholder has initiated a securities class action lawsuit on behalf of investors who purchased Lineage, Inc. common stock in connection with the company's initial public offering (IPO) in July 2024. The Complaint alleges that defendants made misrepresentations regarding Lineage's business, financial results, and industry trends
Class action lawsuits
Neogen Corporation's investors are facing losses due to alleged securities fraud. A class action lawsuit has been filed against the company, seeking to recover these losses. The lawsuit claims that Neogen Corporation made false and misleading statements about the integration with 3M Company's Food Safety Division.
Class action lawsuits
A class action lawsuit has been filed against XPLR Infrastructure, LP, and certain of its officers and directors, alleging securities fraud and other unlawful business practices. The lawsuit concerns XPLR's abandoning of its yieldco business model, suspension of cash distribution to unitholders, and subsequent decline in unit price.
Class action lawsuits
Investors who purchased Spectrum Pharmaceuticals common stock between May 12, 2022, and September 22, 2022, may be entitled to compensation due to allegedly misleading statements made by the company regarding its PINNACLE Study. A law firm, Rosen Law Firm, has filed a class action lawsuit on behalf of investors and
Class action lawsuits
Fiserv, Inc. shareholders who suffered losses as a result of alleged securities fraud between July 24, 2024, and July 22, 2025, may be eligible to recover their losses. A class action lawsuit was filed against Fiserv, Inc. alleging that the company made false statements and concealed the true nature of
Class action lawsuits
Purchasers of Lineage, Inc. common stock in connection with the company's July 2024 initial public offering may be entitled to compensation due to alleged misrepresentations in the registration statement. A class action lawsuit has been filed, and a lead plaintiff must be appointed by September 30, 2025. The
Class action lawsuits
Investors in Alto Neuroscience, Inc. were notified on August 25, 2025, of a class action securities lawsuit alleging securities fraud. The lawsuit specifically targets investors who purchased Alto common stock in connection with the company's initial public offering on February 2, 2024, or those who acquired Alto securities
Class action lawsuits
The Rosen Law Firm reminds investors of common stock of Alto Neuroscience, Inc. that a class action lawsuit has been filed over misleading statements regarding the effectiveness of ALTO-100 in treating major depressive disorder. Key Takeaways: * The lawsuit alleges that Alto's initial public offering documents and subsequent statements
Class action lawsuits
Levi & Korsinsky, a nationally-recognized securities litigation firm, has filed a class action lawsuit against Tesla, Inc. (NASDAQ: TSLA) on behalf of shareholders who suffered losses due to alleged securities fraud. The lawsuit seeks to recover losses from April 19, 2023, to June 22, 2025, when Tesla allegedly made false
